Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea

European Journal of Clinical Investigation

Volumn 44, Issue 11, 2014, Pages 1045-1052

  Ozben, Serkan ^a   Huseyinoglu, Nergiz ^b   Hanikoglu, Ferhat ^c   Guvenc, Tolga Sinan ^b   Yildirim, Binnaz Zeynep ^d   Cort, Aysegul ^c   Ozdem, Sebahat ^c   Ozben, Tomris ^c  

^a Bakirkoy Training and Research Hospital for Psychiatry   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

^c AKDENIZ UNIVERSITY   (Turkey)

^d ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

Author keywords

Advanced oxidation protein products; Ischaemia modified albumin; Obstructive sleep apnea; Oxidative stress; Total antioxidative capacity; Total oxidative status

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ISCHEMIA MODIFIED ALBUMIN; BIOLOGICAL MARKER; ISCHEMIA-MODIFIED ALBUMIN; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ASSAY; ARTICLE; BLOOD ANALYSIS; BLOOD OXYGEN TENSION; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SMOKING; SMOKING HABIT; TOTAL ANTIOXIDATIVE CAPACITY; TOTAL OXIDATIVE STATUS; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; ADVANCED OXIDATION PROTEIN PRODUCTS; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SERUM ALBUMIN; SLEEP APNEA, OBSTRUCTIVE;

EID: 84925945912     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12338     Document Type: Article

References (39)

1. Ozben S, Guvenc TS, Huseyinoglu N, Sanivar HS, Hanikoglu F, Cort A et al. Low serum copeptin levels in patients with obstructive sleep apnea. Sleep Breath 2013;17:1187-92.
2. Jaimchariyatam N, Rodriguez CL, Budur K. Does CPAP treatment in mild obstructive sleep apnea affect blood pressure? Sleep Med 2010;11:837-42.
3. Mancuso M, Bonanni E, LoGerfo A, Orsucci D, Maestri M, Chico L et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 2012;13:632-6.
4. Maeder MT, Munzer T, Rickli H, Schoch OD, Korte W, Hurny C et al. Association between heart rate recovery and severity of obstructive sleep apnea syndrome. Sleep Med 2008;9:753-61.
5. Gabbay IE, Gabbay U, Lavie P. Obesity plays an independent worsening modifying effect on nocturnal hypoxia in obstructive sleep apnea. Sleep Med 2012;13:524-8.
6. Dursun E, Dursun B, Suleymanlar G, Ozben T. Carbonyl stress in chronic renal failure: the effect of haemodialysis. Ann Clin Biochem 2005;42:64-6.
7. Dursun E, Dursun B, Suleymanlar G, Ozben T. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus. Acta Diabetol 2005;42:123-8.
8. Dursun E, Ozben T, Suleymanlar G, Dursun B, Yakupoglu G. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002;40:1009-13.
9. Dursun E, Timur M, Dursun B, Suleymanlar G, Ozben T. Protein oxidation in Type 2 diabetic patients on hemodialysis. J Diabetes Complications 2005;19:142-6.
10. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-13.
11. Ntalapascha M, Makris D, Kyparos A, Tsilioni I, Kostikas K, Gourgoulianis K et al. Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath 2013;17:549-55.
12. Gaze DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet 2009;24:333-41.
13. Kang IG, Jung JH, Kim ST. The effect of obstructive sleep apnea on DNA damage and oxidative stress. Clin Exp Otorhinolaryngol 2013;6:68-72.
14. Kontogianni K, Messini-Nikolaki N, Christou K, Gourgoulianis K, Tsilimigaki S, Piperakis SM. DNA damage and repair capacity in lymphocytes from obstructive sleep apnea patients. Environ Mol Mutagen 2007;48:722-7.
15. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
16. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-9.
17. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
18. Butt M, Khair OA, Dwivedi G, Shantsila A, Shantsila E, Lip GY. Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 2011;58:417-24.
19. Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011;140:534-42.
20. Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 2006;113:239-54.
21. Baguet JP, Barone-Rochette G, Tamisier R, Levy P, Pepin JL. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol 2012;9:679-88.
22. Jelic S, Le Jemtel TH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med 2008;18:253-60.
23. Barcelo A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006;27:756-60.
24. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J 2005;26:2435-9.
25. Ozturk L, Mansour B, Yuksel M, Yalcin AS, Celikoglu F, Gokhan N. Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta 2003;332:83-8.
26. Simiakakis M, Kapsimalis F, Chaligiannis E, Loukides S, Sitaras N, Alchanatis M. Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients. PLoS ONE 2012;7:e39172.
27. Faure P, Tamisier R, Baguet JP, Favier A, Halimi S, Levy P et al. Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J 2008;31:1046-53.
28. Cakatay U, Telci A, Kayali R, Tekeli F, Akcay T, Sivas A. Relation of aging with oxidative protein damage parameters in the rat skeletal muscle. Clin Biochem 2003;36:51-5.
29. Bochi GV, Torbitz VD, Cargnin LP, Sangoi MB, Santos RC, Gomes P et al. Fructose-1, 6-bisphosphate and N-acetylcysteine attenuate the formation of advanced oxidation protein products, a new class of inflammatory mediators, in vitro. Inflammation 2012;35:1786-92.
30. Piwowar A. [Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property]. Pol Merkur Lekarski 2010;28:166-9.
31. Marsche G, Frank S, Hrzenjak A, Holzer M, Dirnberger S, Wadsack C et al. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res 2009;104:750-7.
32. Okur HK, Pelin Z, Yuksel M, Yosunkaya S. Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia. Sleep Breath 2013;17:365-71.
33. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003;124:1386-92.
34. Mehmetoglu I, Kurban S, Yerlikaya FH, Polat H. Obesity is an independent determinant of ischemia-modified albumin. Obes Facts 2012;5:700-9.
35. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of 'Ischemia modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
36. Sinha MK, Vazquez JM, Calvino R, Gaze DC, Collinson PO, Kaski JC. Effects of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart 2006;92:1852-3.
37. Yang LX, Ma SG, Liu H, Xu W. Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels. Clinics 2013;68:968-73.
38. Zhong Y, Wang N, Xu H. Is there a dynamic change in ischemia-modified albumin in patients with obstructive sleep apnea, which often leads to ischemic diseases? Clinics 2013;68:1474.
39. Zhong Y, Wang N, Xu H, Hou X, Xu P, Zhou Z. Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification. Coron Artery Dis 2012;23:538-41.